Advertisement

Presentation and outcome with second line treatment in AL amyloidosis previously sensitive to non-transplant therapies

Giovanni Palladini, Paolo Milani, Andrea Foli, Marco Basset, Francesca Russo, Stefano Perlini and Giampaolo Merlini

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted April 20, 2017
  • Accepted November 1, 2017
  • Published online November 3, 2017.


Contributors 
  • Giovanni Palladini, 1 Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Paolo Milani, 1 Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Andrea Foli, 1 Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Marco Basset, 1 Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Francesca Russo, 1 Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Stefano Perlini, 2 Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
  • Giampaolo Merlini, 1 Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output